vitro vivo antibacterial activities new tricyclic fluoroquinolone vitro vivo antibacterial activities new tricyclic fluoroquinolone acid comparison S- norfloxacin ciprofloxacin potent potent potent ciprofloxacin Staphylococcus Streptococcus Enterococcus faecalis exception Providencia Enterobacteriaceae equal micrograms/ml Against enteric bacteria similar potency potent ciprofloxacin Pseudomonas aeruginosa MICs norfloxacin ciprofloxacin strains micrograms/ml Against Clostridium perfringens Bacteroides fragilis MICs strains micrograms/ml two- active norfloxacin ciprofloxacin activity presence mM Urine pH significant decrease activity urine pH presence serum effect activity general MIC systemic infections Staphylococcus aureus Streptococcus pyogenes Escherichia coli Pseudomonas aeruginosa mice protective effect norfloxacin comparable ciprofloxacin 